Purpose 4/ HPTN 103

Status:Planned
Phase:Open Label
Principal Investigator(s):
Objective:This study focused on PWID acceptability of LEN is not yet on the record and was announced as planned during HPTN 2022 meeting.    Last updated June 10, 2022
Prevention Option(s):PrEP
Study Design:
Arms and Assigned Interventions
Description
Mode of Delivery
ARMs
Start Date
End Date
none
none
Enrollment:0
Age range: ↔ any
Population:Injecting drug users